Anpario (LON:ANP) Hits New 12-Month High – Should You Buy?

Shares of Anpario plc (LON:ANP) hit a new 52-week high during trading on Monday . The company traded as high as GBX 437 ($5.34) and last traded at GBX 431.60 ($5.27), with a volume of 124569 shares trading hands. The stock had previously closed at GBX 407.66 ($4.98).

Analyst Upgrades and Downgrades

Several research analysts have weighed in on ANP shares. Canaccord Genuity Group upped their price objective on shares of Anpario from GBX 380 ($4.64) to GBX 500 ($6.10) and gave the stock a “buy” rating in a report on Tuesday. Canaccord Genuity Group upped their target price on shares of Anpario from GBX 340 ($4.15) to GBX 370 ($4.52) and gave the stock a “buy” rating in a report on Wednesday, September 18th.

Anpario Price Performance

The company has a debt-to-equity ratio of 0.21, a current ratio of 6.15 and a quick ratio of 5.16. The company has a fifty day moving average of GBX 362.62 and a 200-day moving average of GBX 322.22. The firm has a market cap of £74.21 million, a P/E ratio of 2,437.92 and a beta of 0.58.

Insider Transactions at Anpario

In other news, insider Karen Prior sold 14,000 shares of the business’s stock in a transaction that occurred on Friday, December 13th. The stock was sold at an average price of GBX 380 ($4.64), for a total value of £53,200 ($64,949.33). Company insiders own 30.51% of the company’s stock.

Anpario Company Profile

Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.